A New KIT Mutation (N505I) in Acral Melanoma Confers Constitutive Signaling, Favors Tumorigenic Properties, and Is Sensitive to Imatinib
Abstract
no abstract
Journal Articles
Journal of Investigative Dermatology
Year : 2014
BERTOLOTTO-BALLOTTI BERTOLOTTO-BALLOTTI : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-02530592
Submitted on : Friday, April 3, 2020-10:05:54 AM
Last modification on : Thursday, August 4, 2022-4:56:08 PM
Dates and versions
Identifiers
- HAL Id : inserm-02530592 , version 1
- DOI : 10.1038/jid.2013.525
- PUBMED : 24317392
Cite
Maryline Allegra, Damien Giacchero, Coralie Segalen, Nicolas Dumaz, Catherine Butori, et al.. A New KIT Mutation (N505I) in Acral Melanoma Confers Constitutive Signaling, Favors Tumorigenic Properties, and Is Sensitive to Imatinib. Journal of Investigative Dermatology, 2014, 134 (5), pp.1473-1476. ⟨10.1038/jid.2013.525⟩. ⟨inserm-02530592⟩
33
View
0
Download